USANA Health Sciences, Inc. provided earnings guidance for the year 2023. For the year, the company is issuing its initial consolidated net sales of $850 million - $950 million. Diluted EPS of $2.35 - $3.30.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.98 USD | -2.20% |
|
-2.79% | -17.95% |
07-01 | USANA Health Sciences, Inc.(NYSE:USNA) added to Russell Small Cap Comp Value Index | CI |
07-01 | USANA Health Sciences, Inc.(NYSE:USNA) dropped from Russell 3000 Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.95% | 838M | |
+13.33% | 8.13B | |
+6.62% | 7.91B | |
-19.26% | 4.76B | |
-8.54% | 3.63B | |
-20.61% | 3.16B | |
-12.55% | 1.2B | |
-26.47% | 1.12B | |
-7.63% | 892M | |
-11.48% | 761M |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- USANA Health Sciences, Inc. Provides Earnings Guidance for the Fiscal Year 2023